| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glucuronidase beta | 0.530 | 0.846 | 4.0E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1970 | 1970 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
disease | 0.400 | strong | 0.980 | 151 | 13 | 1983 | 2019 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1983 | 2015 | ||||||||
|
ornithine decarboxylase 1 | 0.510 | 0.731 | 0.17 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1984 | 2011 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.100 | None | 0.949 | 39 | 2 | 1986 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1986 | 1992 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 1987 | 2020 | ||||||||
|
fucosyltransferase 4 | 0.505 | 0.731 | 7.7E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1987 | 1987 | ||||||||
|
hes related family bHLH transcription factor with YRPW motif 2 | 0.572 | 0.731 | 0.89 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 1.000 | strong | 0.961 | 648 | 189 | 1989 | 2020 | ||||||||
|
fibroblast activation protein alpha | 0.496 | 0.808 | 1.9E-28 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1990 | 2018 | ||||||||
|
facioscapulohumeral muscular dystrophy 1A | 0.638 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | |||||||||
|
cytochrome c oxidase III | 0.546 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | |||||||||
|
MCC regulator of WNT signaling pathway | 0.568 | 0.731 | 4.7E-16 |
|
disease | 0.400 | None | 1.000 | 18 | 1 | 1991 | 2018 | ||||||||
|
glucagon | 0.431 | 0.885 | 3.5E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
signal recognition particle 19 | 0.931 | 0.192 | 6.9E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.912 | 68 | 0 | 1992 | 2019 | ||||||||
|
DCC netrin 1 receptor | 0.471 | 0.808 | 0.99 |
|
disease | 0.090 | None | 0.889 | 9 | 0 | 1992 | 2016 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.100 | None | 0.955 | 22 | 0 | 1993 | 2018 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.100 | None | 1.000 | 15 | 2 | 1993 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 1993 | 2019 |